How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

LI

NASDAQ:LIXT
Get a brief AI stock analysisSaves ~ 15 minutes of your time

LI

Lixte Biotechnology Holdings IncNASDAQ LIXT Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is LIXT undervalued compared to its fair value?

The fair value of LIXT stock is hidden USD. Relative to the market price of 2.31 USD Lixte Biotechnology Holdings Inc is hidden.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. The company is headquartered in East Setauket, New York and currently employs 3 full-time employees. The company went IPO on 2007-09-21. The Compan...[More about valuation]

Lixte Biotechnology Holdings Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.006 $B

Price:

2.31 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.491

FINANCIALS

Lixte Biotechnology Holdings financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.0052 B
0.0049 B

Financial Position Analysis

Assets

0.0052 B
Current Assets
0.0052 B
Total non-current assets

Total current liabilities
0.0003 B
Total non-current liabilities

Cash Flow Statement

-0.0009 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0009 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Lixte Biotechnology Holdings fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is LIXT attractive for investment based on fundamental analysis?

LIXT stock rating is hidden. Lixte Biotechnology Holdings is a hidden by Eyestock methodology.

Get LIXT Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

LIXT analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for LIXT to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Lixte Biotechnology Holdings Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Lixte Biotechnology Holdings Inc dividends

LIXT dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About LIXT stock

About the company Lixte Biotechnology Holdings Inc

Market cap $B

0.006

Dividend yield

Shares outstanding

16.6466 B

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. The company is headquartered in East Setauket, New York and currently employs 3 full-time employees. The company went IPO on 2007-09-21. The Company’s product pipeline is primarily focused on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers, and encompasses two categories of compounds at various stages of pre-clinical and clinical development that has the therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. The firm has developed two series of pharmacologically active drugs, the LB-100 series and the LB-200 series. The LB-100 series consists of structures, which is treated not only several types of cancer but also vascular and metabolic diseases. The LB-200 series contains compounds, which are useful for the treatment of chronic hereditary diseases.

LIXT profile

  • Ticker

    LIXT

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    21 September 2007

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    3

  • City

    East Setauket

  • Address

    No. 2, 248 Route 25A

  • Cusip

    539319202